Description: PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company trades in and distributes drugs, medical devices, medical supplies, extracts, and herbals; and operates laboratory. It also provides COVID-19 test services, including rapid diagnostic test antigen; reverse transcription polymerase chain reaction, and genose. The company also exports its products. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk operates as a subsidiary of PT. Bio Farma.
Home Page: indofarma.id
Jalan Indofarma No. 1
Bekasi,
17530
Indonesia
Phone:
62 21 8832 3971
Officers
| Name | Title |
|---|---|
| Mr. Arief Pramuhanto | Pres Director |
| Mr. Jejen Nugaha | Production & Supply Chain Director and Director |
| Mr. Fudoli Rustam | Marketing Mang. |
| Dr. Kamelia Faisal | Director of Sales & Marketing and Director |
| Mr. Sigit Prakosa C.A., S.E. | Head of Internal Audit Unit |
| Hilda Yani | Corp. Sec. |
| Ms. Weny Maulatsih | Sec. of Board of Commissioners |
Exchange: JK
Country: ID : Indonesia
Currency: Indonesian Rupiah (Rp)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 8.9113 |
| Price-to-Sales TTM: | 1.2483 |
| IPO Date: | 2001-04-17 |
| Fiscal Year End: | December |
| Full Time Employees: | 1179 |